Form 8-K - Current report:
SEC Accession No. 0001664710-25-000052
Filing Date
2025-05-29
Accepted
2025-05-29 06:58:59
Documents
29
Period of Report
2025-05-28
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kros-20250528.htm   iXBRL 8-K 44587
2 EX-99.1 exhibit99152925pr.htm EX-99.1 16884
3 EX-99.2 exhibit992.htm EX-99.2 21694
8 exhibit992001.jpg GRAPHIC 88520
9 exhibit992002.jpg GRAPHIC 208713
10 exhibit992003.jpg GRAPHIC 143787
11 exhibit992004.jpg GRAPHIC 127870
12 exhibit992005.jpg GRAPHIC 162470
13 exhibit992006.jpg GRAPHIC 135262
14 exhibit992007.jpg GRAPHIC 151908
15 exhibit992008.jpg GRAPHIC 143462
16 exhibit992009.jpg GRAPHIC 128439
17 exhibit992010.jpg GRAPHIC 92479
18 exhibit992011.jpg GRAPHIC 97415
19 exhibit992012.jpg GRAPHIC 116432
20 exhibit992013.jpg GRAPHIC 115014
21 exhibit992014.jpg GRAPHIC 52004
  Complete submission text file 0001664710-25-000052.txt   2693150

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20250528.xsd EX-101.SCH 2166
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kros-20250528_def.xml EX-101.DEF 17224
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20250528_lab.xml EX-101.LAB 28316
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20250528_pre.xml EX-101.PRE 17510
31 EXTRACTED XBRL INSTANCE DOCUMENT kros-20250528_htm.xml XML 4116
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 25997635
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)